Error: Could not add to watchlist. X
+ Watchlist

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

FBDIX:US
NASDAQ GM
146.26
USD
2.01
1.39%
As of 9:29 AM EDT 4/25/2017
Fund Type
Open-End Fund
52Wk Range
114.25 - 151.42
1 Yr Return
15.59%
YTD Return
12.80%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
144.25
52Wk Range
114.25 - 151.42
1 Yr Return
14.42%
YTD Return
12.80%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 04/25/2017)
146.26
Total Assets (b USD) (on 03/31/2017)
1.308
Inception Date
09/15/1997
Last Dividend (on 12/15/2016)
1.7284
Dividend Indicated Gross Yield
1.18%
Fund Managers
EVAN MCCULLOCH
Front Load Fee
5.75%
Back Load Fee
1.00%
Redemption Fee
0.00%
12b-1 Fee
0.24%
Current Mgmt Fee
0.57%
Expense Ratio
0.98%

Top Fund Holdings

Name Position Value % of Fund
1.08 m 134.00 m 9.61
334.76 k 91.53 m 6.56
667.50 k 89.22 m 6.40
641.30 k 77.75 m 5.57
480.14 k 73.88 m 5.30
167.01 k 64.72 m 4.64
854.10 k 58.01 m 4.16
351.90 k 57.74 m 4.14
453.60 k 49.60 m 3.56
217.98 k 37.20 m 2.67
Profile
Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.
Address
Franklin Templeton Investments
One Franklin Parkway
Building 970
1st Floor
San Mateo, CA 94403
Phone
1-800-632-2350